Growth Hormone Response during Oral Glucose Tolerance Test: The Impact of Assay Method on the Estimation of Reference Values in Patients with Acromegaly and in Healthy Controls, and the Role of Gender, Age, and Body Mass Index
Author(s) -
Ayman M. Arafat,
Matthias Möhlig,
Martin O. Weickert,
F. H. Perschel,
J Purschwitz,
Joachim Spranger,
Christian J. Strasburger,
Christof Schöfl,
A. Pfeiffer
Publication year - 2008
Publication title -
the journal of clinical endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.206
H-Index - 353
eISSN - 1945-7197
pISSN - 0021-972X
DOI - 10.1210/jc.2007-2084
Subject(s) - acromegaly , medicine , liter , body mass index , endocrinology , growth hormone , basal (medicine) , confounding , confidence interval , pituitary disease , gastroenterology , hormone , insulin
Besides the measurement of IGF-I, GH suppression during an oral glucose tolerance test is recommended to assess the biochemical status in acromegaly. However, the development of highly sensitive and specific GH assays necessitates a critical reevaluation of criteria for diagnosis and follow-up of disease activity.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom